Yahoo
    Tokyo - Delayed Quote JPY

    Shionogi & Co., Ltd. (4507.T)

    3,012.00 +23.00 (+0.77%)
    At close: October 30 at 3:30:00 PM GMT+9
    Loading Chart for 4507.T
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    SGIOY vs. UTHR: Which Stock Is the Better Value Option?

    SGIOY vs. UTHR: Which Stock Is the Better Value Option?
    Zacks 1d ago
    Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates

    Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates
    Zacks 3d ago
    How Investors Are Reacting To Shionogi (TSE:4507) Clinical Trial Results

    How Investors Are Reacting To Shionogi (TSE:4507) Clinical Trial Results
    Simply Wall St. 6d ago
    IDWeek 2026: Shionogi Presents U.S. Analysis of Real-World Data Showing Early Treatment Initiation with Fetroja®/Fetcroja® (cefiderocol) Improved Clinical Outcomes in Patients with Respiratory Infections

    IDWeek 2026: Shionogi Presents U.S. Analysis of Real-World Data Showing Early Treatment Initiation with Fetroja®/Fetcroja® (cefiderocol) Improved Clinical Outcomes in Patients with Respiratory Infections
    Business Wire 11d ago
    Shionogi and F2G’s invasive aspergillosis drug shows long-term benefit

    Shionogi and F2G’s invasive aspergillosis drug shows long-term benefit
    Clinical Trials Arena 11d ago
    Shionogi & Co. (SGIOY) Upgraded to Buy: Here's What You Should Know

    Shionogi & Co. (SGIOY) Upgraded to Buy: Here's What You Should Know
    Zacks 17d ago
    Can Shionogi (TSE:4507) Support Its Price With Earnings After IntraBio?

    Can Shionogi (TSE:4507) Support Its Price With Earnings After IntraBio?
    Simply Wall St. 22d ago
    Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout

    Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout
    Pharmaceutical Technology 26d ago
    Shionogi acquires rare disease startup IntraBio for $2 billion

    Shionogi acquires rare disease startup IntraBio for $2 billion
    Quartz 26d ago
    Shionogi pays $2B to acquire a rare disease startup

    Shionogi pays $2B to acquire a rare disease startup
    BioPharma Dive 26d ago
    Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.

    Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.
    Business Wire 27d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: